
Obesity is a risk factor for cardiotoxicity in chemotherapy-treated patients with breast cancer
Anthracyclines remain a cornerstone of breast cancer therapy in combination with new-generation targeted drugs such…
Anthracyclines remain a cornerstone of breast cancer therapy in combination with new-generation targeted drugs such…
Many physicians are not telling cancer patients about the cardiotoxicity risks of treatments and may…
In patients with breast cancer, obesity was significantly associated with a greater risk of developing…
A protocol developed at the European Institute of Oncology (IEO), based on an echocardiogram and…